Retrieve available abstracts of 21 articles: HTML format
Single Articles
June 2025
LIU J, Xu J, Sun R, Wang X, et al MARCH1, transcriptionally regulated by POU2F2, facilitates acute myeloid leukemia
progression via inducing MYCT1 degradation.
Oncogene. 2025 Jun 18. doi: 10.1038/s41388-025-03464. PubMedAbstract available
LI YQ, Liu D, Wang LL, Shao YL, et al WTAP-mediated m(6)A methylation of PHF19 facilitates cell cycle progression by
remodeling the accessible chromatin landscape in t(8;21) AML.
Oncogene. 2025;44:1504-1516. PubMedAbstract available
XIE Y, Zhao R, Zheng Y, Li Y, et al Targeting KPNB1 suppresses AML cells by inhibiting HMGB2 nuclear import.
Oncogene. 2025;44:1646-1661. PubMedAbstract available
May 2025
YAO L, Zhang X, Li X, Xu J, et al circAFF2 promotes the development of AML by binding to PML mRNA.
Oncogene. 2025;44:1234-1244. PubMedAbstract available
March 2025
ZHANG L, Wang X, Hu D, Li S, et al SUMOylation facilitates the stability of BCR-ABL to promote chronic myeloid
leukemia progression.
Oncogene. 2025 Mar 27. doi: 10.1038/s41388-025-03350. PubMedAbstract available
February 2025
TIAN X, Zhang L, Xiang G, Tang Y, et al Single-cell multiomics reveals a gene regulatory circuit driving leukemia cell
differentiation.
Oncogene. 2025 Feb 22. doi: 10.1038/s41388-025-03309. PubMedAbstract available
VALIMA E, Varis V, Bureiko K, Lempiainen JK, et al SUMOylation inhibition potentiates the glucocorticoid receptor to program growth
arrest of acute lymphoblastic leukemia cells.
Oncogene. 2025 Feb 14. doi: 10.1038/s41388-025-03305. PubMedAbstract available
ZHANG J, Zhai J, Wong CC, Chen H, et al Correction: A novel amplification gene PCI domain containing 2 (PCID2) promotes
colorectal cancer through directly degrading a tumor suppressor promyelocytic
leukemia (PML).
Oncogene. 2025 Feb 12. doi: 10.1038/s41388-025-03304. PubMed
November 2024
DUAN C, Lin X, Zou W, He Q, et al Targeting DDX3X eliminates leukemia stem cells in chronic myeloid leukemia by
blocking NT5DC2 mRNA translation.
Oncogene. 2024 Nov 8. doi: 10.1038/s41388-024-03215. PubMedAbstract available
ZHANG C, Hao T, Bortoluzzi A, Chen MH, et al Sex-dependent differences in hematopoietic stem cell aging and leukemogenic
potential.
Oncogene. 2024 Nov 1. doi: 10.1038/s41388-024-03197. PubMedAbstract available
August 2024
SERGIO I, Varricchio C, Patel SK, Del Gaizo M, et al Notch3-regulated microRNAs impair CXCR4-dependent maturation of thymocytes
allowing maintenance and progression of T-ALL.
Oncogene. 2024;43:2535-2547. PubMedAbstract available
June 2024
WANG G, Zhang W, Ren J, Zeng Y, et al The DNA damage-independent ATM signalling maintains CBP/DOT1L axis in MLL
rearranged acute myeloid leukaemia.
Oncogene. 2024;43:1900-1916. PubMedAbstract available
April 2024
SAFFERTHAL C, Rohde K, Fulda S Correction: Therapeutic targeting of necroptosis by Smac mimetic bypasses
apoptosis resistance in acute myeloid leukemia cells.
Oncogene. 2024 Apr 29. doi: 10.1038/s41388-024-03022. PubMed
March 2024
GUO T, Wang Y, Sun X, Hou S, et al Loss of RNA-binding protein CELF2 promotes acute leukemia development via
FAT10-mTORC1.
Oncogene. 2024 Mar 21. doi: 10.1038/s41388-024-03006. PubMedAbstract available
December 2023
LEI H, Xu H, Yang L, Wang Y, et al USP47 stabilizes YBX1 to promote the progression of acute myeloid leukemia.
Oncogene. 2023 Dec 16. doi: 10.1038/s41388-023-02921. PubMed
NOURA M, Matsuo H, Yasuda T, Tsuzuki S, et al Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute
lymphoblastic leukemia.
Oncogene. 2023 Dec 15. doi: 10.1038/s41388-023-02913. PubMedAbstract available
DI MAMBRO A, Arroyo-Berdugo Y, Fioretti T, Randles M, et al SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML.
Oncogene. 2023;42:3670-3683. PubMedAbstract available
November 2023
ERKNER E, Hentrich T, Schairer R, Fitzel R, et al The ROR?/SREBP2 pathway is a master regulator of cholesterol metabolism and
serves as potential therapeutic target in t(4;11) leukemia.
Oncogene. 2023 Nov 29. doi: 10.1038/s41388-023-02903. PubMedAbstract available
October 2023
XIE X, Zhang W, Zhou X, Xu B, et al Low doses of IFN-gamma maintain self-renewal of leukemia stem cells in acute myeloid
leukemia.
Oncogene. 2023 Oct 23. doi: 10.1038/s41388-023-02874. PubMedAbstract available
September 2023
MA H, Cui J, Liu Z, Fang W, et al Blockade of de novo pyrimidine biosynthesis triggers autophagic degradation of
oncoprotein FLT3-ITD in acute myeloid leukemia.
Oncogene. 2023 Sep 26. doi: 10.1038/s41388-023-02848. PubMedAbstract available
PAWLIKOWSKA P, Delestre L, Gregoricchio S, Oppezzo A, et al FANCA deficiency promotes leukaemic progression by allowing the emergence of
cells carrying oncogenic driver mutations.
Oncogene. 2023;42:2764-2775. PubMedAbstract available